HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies. Frange P et al, J Antimicrob Chemother. 2015 Jul;70(7):2084-9. Posted on June 30th, 2015 - Pr Pedro Cahn Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1–Infected Individuals. Okulicz JF et al, JAMA Intern Med. 2015 Jan;175(1):88-99. Posted on June 2nd, 2015 - Pr Anton Pozniak Back to Home page
Back to Home page